| P50 | author | Nirbhay Kumar | Q56789145 |
| P2093 | author name string | Drew Hannaman | |
| | Dietlind L Gerloff | |
| | Barry Ellefsen | |
| | Dibyadyuti Datta | |
| | Geetha P Bansal | |
| P2860 | cites work | Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle | Q81792807 |
| | OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups | Q24538674 |
| | DNA vaccines: designing strategies against parasitic infections | Q24801950 |
| | Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41 | Q27230051 |
| | Structure of the Plasmodium 6-cysteine s48/45 domain | Q27678432 |
| | Proteins of the malaria parasite sexual stages: expression, function and potential for transmission blocking strategies | Q27973462 |
| | PlasmoDB: a functional genomic database for malaria parasites | Q29618004 |
| | A central role for P48/45 in malaria parasite male gamete fertility | Q30043154 |
| | Pfs47, paralog of the male fertility factor Pfs48/45, is a female specific surface protein in Plasmodium falciparum | Q30043157 |
| | A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli | Q33485233 |
| | Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility | Q33553363 |
| | A research agenda for malaria eradication: vaccines | Q33818046 |
| | The prime-boost strategy: exciting prospects for improved vaccination | Q33876983 |
| | posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate | Q33883252 |
| | A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum | Q33897645 |
| | Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies | Q34000822 |
| | Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum | Q34015845 |
| | Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial | Q34043843 |
| | Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120. | Q34146374 |
| | Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination | Q34177472 |
| | The role of glycosylation in protein antigenic properties | Q34607244 |
| | DNA vaccines: ready for prime time? | Q34824179 |
| | Technologies for enhanced efficacy of DNA vaccines | Q35802958 |
| | Evaluation of the Impact of Codon Optimization and N-Linked Glycosylation on Functional Immunogenicity of Pfs25 DNA Vaccines Delivered by In Vivo Electroporation in Preclinical Studies in Mice | Q35998776 |
| | Plasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure | Q36138015 |
| | Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations. | Q36228933 |
| | Human clinical trials of plasmid DNA vaccines | Q36314237 |
| | Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum | Q36348052 |
| | Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito | Q36351262 |
| | Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation | Q36428352 |
| | Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice | Q36670217 |
| | Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons | Q36941152 |
| | Electroporation-based DNA immunisation: translation to the clinic | Q36981658 |
| | Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding | Q37713285 |
| | Electroporation for DNA immunization: clinical application | Q37744992 |
| | DNA vaccines: an historical perspective and view to the future | Q37825523 |
| | Overlooked post-translational modifications of proteins in Plasmodium falciparum: N- and O-glycosylation -- a review | Q37827726 |
| | Electroporation delivery of DNA vaccines: prospects for success | Q37870313 |
| | Reduced immunogenicity of Plasmodium falciparum gamete surface antigen (Pfs48/45) in mice after disruption of disulphide bonds - evaluating effect of interferon-γ-inducible lysosomal thiol reductase. | Q39246146 |
| | Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization | Q39504399 |
| | A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation | Q40665953 |
| | Plasmodium falciparum: heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 in recombinant vaccinia virus-infected cells | Q41003251 |
| | Suggestive evidence for Darwinian Selection against asparagine-linked glycans of Plasmodium falciparum and Toxoplasma gondii | Q41910735 |
| | Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes | Q43032460 |
| | Properties of epitopes of pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of plasmodium falciparum | Q44143594 |
| | Transmission blocking malaria vaccines | Q44145217 |
| | Plasmodium falciparum transmission blocking monoclonal antibodies recognize monovalently expressed epitopes | Q44146493 |
| | Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy | Q44161423 |
| | Biosynthesis of the target antigens of antibodies blocking transmission of Plasmodium falciparum | Q44165535 |
| | Enhancement of immune responses to an HBV DNA vaccine by electroporation | Q44643829 |
| | Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies. | Q47829675 |
| | Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. | Q47837358 |
| | Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast | Q47857505 |
| | Detailed functional characterization of glycosylated and nonglycosylated variants of malaria vaccine candidate PfAMA1 produced in Nicotiana benthamiana and analysis of growth inhibitory responses in rabbits | Q47883813 |
| | Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12. | Q47998054 |
| | Production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expressing bacterial PNGase F. | Q48007592 |
| | Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures | Q68897064 |
| | Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial | Q73234978 |
| | Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen | Q73509627 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | electroporation | Q1142521 |
| | malaria vaccine | Q6741353 |
| | malaria transmission | Q56928847 |
| P304 | page(s) | 264-272 | |
| P577 | publication date | 2016-11-29 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation | |
| P478 | volume | 35 | |